Skip to content

Interventional Reference Levels (IRL) in Digestive Endoscopy

Interventional Reference Levels (IRL) in Digestive Endoscopy

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06363682
Acronym
EndoscopX
Enrollment
1000
Registered
2024-04-12
Start date
2024-04-01
Completion date
2024-06-11
Last updated
2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Each Endoscopic Intervention Using X-rays

Keywords

scopy, X rays, digestive endoscopy, interventional reference levels

Brief summary

Scopy uses X-rays and is not without risk (deterministic and stochastic effects) for the patient and the nursing staff present in the room at the time of an endoscopic procedure requiring its use: its use must be reasoned with a benefit/risk balance in favour of carrying out the interventional procedure. In France, there is currently no multicentre study exploring the radiation doses used for each type of endoscopic procedure. Main objective: To define IRL (interventional reference levels) adapted to each type of endoscopic procedure. Secondary objective(s) : * Application of regulatory texts * Assessment of patient radiation protection * Radiation protection assessment for workers

Detailed description

Prospective data collection using an e-CRF available via Easymedstat. Data completed during the endoscopy procedure Completion of a questionnaire by the practitioner who performed the procedure afterwards, including the scopy doses used during the procedure, the type of scopy, the type of intention-to-treat

Interventions

PROCEDUREERCP

ERCP of the biliary duct ou the pancreatic duct, with or without the use of a stent, in a context of gallstone or tumor or other

PROCEDUREendoscopic ultrasound

The use of endoscopic ultrasound in diverse situation with the necessity of using X rays

PROCEDUREgastroscopy

The diverse procedure in witch scopy is use in orders to place or switch or remove an oesophageal or gastroduodenal stent during a gastroscopy. Or for oesophageal or gastroduodenal dilatation.

PROCEDUREColonoscopy

The diverse procedure in witch scopy is use during a colonoscopy

PROCEDUREplacement of a nasojejunal tube

placement of a nasojejunal tube for enteral nutritional support

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients who have received an X-ray dose during an endoscopic procedure

Exclusion criteria

* No X-rays produced * Medical indication not in favour of the scopy procedure in view of the benefit/risk balance

Design outcomes

Primary

MeasureTime frameDescription
To define IRL (interventional reference levels) adapted to each type of endoscopic procedure.From enrollment to the end of data collection at 3 monthsIRL is the mean for all endoscopic procedure using scopy, it is calculated by multiplying the PDS in Gy.cm2 with the time during witch the patient as been expose to Xrays during the procedure

Secondary

MeasureTime frameDescription
Application of regulatory textsFrom enrollment to the end of data collection at 3 monthsyes or no variable : the good delivery of information to the patient about the use of X rays during the procedure ;up-to-date radiation protection training for staff; up-to-date radiation protection training for patient
Assessment of patient radiation protectionFrom enrollment to the end of data collection at 3 monthsyes or no variable : optimising X-ray doses
Radiation protection assessment for workersFrom enrollment to the end of data collection at 3 monthsyes or no variable : Wearing ACTIVE and/or PASSIVE dosimeters in accordance with regulations; Wearing personal protective equipment

Countries

France

Contacts

Primary ContactCHEVAUX Doctor CHEVAUX Jean-Baptiste, PhD
jb.chevaux@chru-nancy.fr+33 3 83 15 41 49

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026